January 06, 2014
1 min read

FDA approves lacrimal duct balloon catheter

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

The U.S. Food and Drug Administration has approved the OphtaCath lacrimal duct balloon catheter from FCI Ophthalmics, according to a press release.

The OphtaCath achieves dilation of the lacrimal duct and treats the symptoms of epiphora, according to the release. It is a less invasive alternative to incisional procedures and eliminates the placement of tubes.

It is packaged in sterile 2-mm or 3-mm kits with one or two balloon catheters and a disposable inflation device.